New! Search for patents from more than 100 countries including Australia, Brazil, Sweden and more

GB0516379D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0516379D0
GB0516379D0 GB0516379A GB0516379A GB0516379D0 GB 0516379 D0 GB0516379 D0 GB 0516379D0 GB 0516379 A GB0516379 A GB 0516379A GB 0516379 A GB0516379 A GB 0516379A GB 0516379 D0 GB0516379 D0 GB 0516379D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0516379A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0516379A priority Critical patent/GB0516379D0/en
Publication of GB0516379D0 publication Critical patent/GB0516379D0/en
Application status is Ceased legal-status Critical

Links

GB0516379A 2005-08-09 2005-08-09 Compounds Ceased GB0516379D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0516379A GB0516379D0 (en) 2005-08-09 2005-08-09 Compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0516379A GB0516379D0 (en) 2005-08-09 2005-08-09 Compounds
PCT/EP2006/007875 WO2007017264A2 (en) 2005-08-09 2006-08-07 Pyrrolopyridinederivatives as modulators of the cannabinoid receptor for the treatment of immune and inflammatory disorders

Publications (1)

Publication Number Publication Date
GB0516379D0 true GB0516379D0 (en) 2005-09-14

Family

ID=34984350

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0516379A Ceased GB0516379D0 (en) 2005-08-09 2005-08-09 Compounds

Country Status (2)

Country Link
GB (1) GB0516379D0 (en)
WO (1) WO2007017264A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009035818A1 (en) 2007-09-10 2009-03-19 Calcimedica, Inc. Compounds that modulate intracellular calcium
HUE027707T2 (en) 2007-11-30 2016-10-28 Zynerba Pharmaceuticals Inc Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
US8389567B2 (en) 2007-12-12 2013-03-05 Calcimedica, Inc. Compounds that modulate intracellular calcium
EP2321303A4 (en) 2008-08-27 2011-11-16 Calcimedica Inc Compounds that modulate intracellular calcium
US8524763B2 (en) 2008-09-22 2013-09-03 Calcimedica, Inc. Inhibitors of store operated calcium release
US8524727B2 (en) 2009-03-30 2013-09-03 Astellas Pharma Inc. Pyrimidine compound
WO2011034962A2 (en) 2009-09-16 2011-03-24 Calcimedica Inc. Compounds that modulate intracellular calcium
UA109550C2 (en) 2010-07-29 2015-09-10 Condensed cyclic compounds pyridine
SG11201504231PA (en) * 2012-11-30 2015-07-30 Kyowa Hakko Kirin Co Ltd Nitrogen-containing heterocyclic compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058869A2 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
GB0017256D0 (en) * 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
TW200522944A (en) * 2003-12-23 2005-07-16 Lilly Co Eli CB1 modulator compounds
KR20070034049A (en) * 2004-06-09 2007-03-27 글락소 그룹 리미티드 Pyrrolopyridine derivatives

Also Published As

Publication number Publication date
WO2007017264A3 (en) 2007-04-12
WO2007017264A2 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
EG25704A (en) Safe-pool
TWI389690B (en) Novel compounds
TWI361186B (en) New compounds
TWI299039B (en) Pyrrolindine compounds
EP1971608A4 (en) Spiroketals
GB0507327D0 (en) Reflect-a-bolt
DE602006009835D1 (en) Nthalten
DE602006009217D1 (en) Polypeptidmutageneseverfahren
GB0511335D0 (en) Grach
DE502005007477D1 (en) Delta-sigma-modulator
GB0503200D0 (en) Turbilites
DE602006006047D1 (en) Primaten t-lymphotrophische viren
DE602006017237D1 (en) Clostridientoxinaktivitätstests
DE602006018441D1 (en) Arabinofuranosidasen
DE602005026467D1 (en) Offshore-system
DE602006019295D1 (en) Delta-sigma-modulator
GB0500013D0 (en) Diallerguard
GB0512195D0 (en) iCorcost3
DE602005019635D1 (en) Schädelschutzzelle
DE602006016147D1 (en) Imidazobenzdiazepinderivate
GB0504734D0 (en) Adbox
DE602006013847D1 (en) Polyurethandispergierharz
DE602006014800D1 (en) Reibschweisswerkzeug
GB0507425D0 (en) Drydam
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)